Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial)

American Journal of Cardiology

Volumn 80, Issue 9 B, 1997, Pages

  Herlitz, Johan ^a   Waagstein, Finn ^a   Lindqvist, Jonny ^a   Swedberg, Karl ^a   Hjalmarson, Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030698868     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00838-2     Document Type: Conference Paper

References (19)

1. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1975;1022-1036.
2. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure A systemic overview of randomized controlled trials . Eur Heart J. 18:1997;560-565.
3. Herlitz J, Elmfeldt D, Hjalmarson Å, Holmberg S, Málek I, Nyberg G, Rydén LA, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C. Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction. Am J Cardiol. 51:1983;1282-1288.
4. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction ISIS-1 . Lancet. ii:1986;57-66.
5. Hjalmarson Å, Elmfeldt D, Herlitz J, Holmberg S, Málek I, Nyberg G, Rydén LA, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction a double-blind randomised trial . Lancet. ii:1981;823-827.
6. Brydon WG, Smith AF. An appraisal of routine methods for the determination of the anodal isoenzymes of lactate dehydrogenase. Clin Chim Acta. 43:1973;361-369.
7. Bradley JW. Distribution-free statistical tests. London: Prentice-Hall, 1968:68-86.
8. A randomized trial of beta-blockade in heart failure the Cardiac Insufficiency Bisoprolol Study (CIBIS) . Circulation. 90:1994;1765-1773.
9. Swedberg K, Hjalmarson Å, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy during treatment with beta-receptor blockade. Lancet. i:1979;1374-1376.
10. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson Å. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy results of the Metoprolol in Dilated Cardiomyopathy (MDC) Trial. A randomised, double-blind, placebo controlled multicentre study . Lancet. 342:1993;1441-1446.
11. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
12. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 304:1981;801-807.
13. The β-Blocker Heart Attack Trial (BHAT). JAMA. 246:1981;2073-2074.
14. Metoprolol in Acute Myocardial Infarction (MIAMI) a randomised placebo-controlled international trial . Eur Heart J. 6:1985;199-226.
15. Pedersen TR. The Norwegian multicenter study of timolol after myocardial infarction. Circulation. 67:(suppl 1):1983;I-49-I-53.
16. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 73:1986;503-510.
17. Hjalmarson Å, Waagstein F. The role of beta-blockers in the treatment of cardiomyopathy and ischemic heart failure. Drugs. 47:(suppl 4):1994;31-40.
18. Ertl G, Neubauer S, Gaudron P, Horn M, Hu K, Tian R, Krahe T. Beta-blockers in cardiac failure. Eur Heart J. 15:(suppl C):1994;16-24.
19. Waagstein F. The role of beta-blockers in dilated cardiomyopathy. Curr Opin Cardiol. 10:1995;322-331.